Table 1.
Baseline characteristics of all participants with disabilities prior to the CHD onset
| Characteristics | Overall population n = 6419 | CHD group n = 688 |
Non-CHD group n = 5731 |
P-value |
|---|---|---|---|---|
| Age, yrs | 50.77 ± 9.88 | 52.95 ± 7.17 | 50.51 ± 10.13 | < 0.001* |
| Male, n (%) | 3046 (47.5) | 359 (52.2) | 2687 (46.9) | 0.010* |
| Classification of disabilities, n (%) | < 0.001* | |||
| Physical disabilities | 3594(56.0) | 421 (61.2) | 3173 (55.4) | |
| Visual disabilities | 1346 (21.0) | 160 (23.3) | 1186 (20.7) | |
| Hearing & speech disabilities | 370 (5.8) | 30 (4.4) | 340 (5.9) | |
| Intellectual & mental disabilities | 1109 (17.3) | 77 (11.2) | 1032 (18.0) | |
| Whether physical disabilities, n (%) | 0.004* | |||
| Physical disabilities | 3594(56.0) | 421 (61.2) | 3173 (55.4) | |
| Other disabilities | 2825 (44.0) | 267 (38.8) | 2558 (44.6) | |
| Grading of disabilities, n (%) | 0.847 | |||
| Very severe disability | 502 (7.8) | 50 (7.3) | 452 (7.9) | |
| Severe disability | 991 (15.4) | 101 (14.7) | 890 (15.5) | |
| Moderate disability | 2224 (34.6) | 240 (34.9) | 1984 (34.6) | |
| Mild disability | 2702 (42.2) | 297 (43.1) | 2405 (42.0) | |
| Comorbidities, n (%) | ||||
| Hypertension | 2370 (36.9) | 369 (53.6) | 2001 (34.9) | < 0.001* |
| Diabetes mellitus | 725 (11.3) | 132 (19.2) | 593 (10.3) | < 0.001* |
| Chronic kidney disease | 901 (14.0) | 107 (15.6) | 794 (13.9) | 0.223 |
| Fatty liver disease | 600 (9.3) | 54 (7.8) | 546 (9.5) | 0.166 |
| Abnormal ECG, n (%) | 756 (11.8) | 130 (18.9) | 626 (10.9) | < 0.001* |
| Heart rate, beats/min | 78.15 ± 10.23 | 78.53 ± 11.51 | 78.10 ± 10.07 | 0.351 |
| BMI, kg/m2 | 24.01 ± 3.54 | 24.33 ± 3.52 | 23.97 ± 3.54 | 0.011* |
| Overweight, n (%) | 3072(47.9) | 349(50.7) | 2723(47.5) | 0.215 |
| Blood pressure, mmHg | ||||
| Systolic | 132.55 ± 20.23 | 135.3 ± 20.83 | 132.22 ± 20.13 | < 0.001* |
| Diastolic | 78.77 ± 12.51 | 80.38 ± 12.82 | 78.57 ± 12.46 | < 0.001* |
| Metabolic biomarkers | ||||
| FBG, mmol/L | 5.49 ± 1.44 | 5.84 ± 1.93 | 5.45 ± 1.36 | < 0.001* |
| TC, mmol/L | 4.78 ± 0.92 | 4.93 ± 0.96 | 4.76 ± 0.91 | < 0.001* |
| TG, mmol/L | 1.25 (0.89,1.84) | 1.38 (1.01,1.99) | 1.24 (0.88,1.83) | < 0.001* |
| Alb, g/L | 43.58 ± 2.30 | 43.48 ± 2.27 | 43.59 ± 2.31 | 0.214 |
| Glo, g/L | 28.72 ± 3.72 | 28.75 ± 3.63 | 28.72 ± 3.74 | 0.819 |
| UA, mol/L | 313.80 (262.00, 373.83) | 323.15 (266.20, 376.55) | 312.80 (261.20, 373.70) | 0.102 |
| SCr, μmol/L | 63.43 ± 22.93 | 63.13 ± 17.61 | 63.46 ± 23.49 | 0.717 |
| SU, mmol/L | 4.90 (4.20, 5.80) | 5.00 (4.40, 5.90) | 4.9 (4.20, 5.80) | 0.001* |
| Hb, g/L | 137.83 ± 16.15 | 136.73 ± 15.43 | 137.97 ± 16.24 | 0.059 |
| RBC, 1012/L | 4.71 ± 0.47 | 4.70 ± 0.48 | 4.72 ± 0.47 | 0.293 |
| WBC, 109/L | 6.53 ± 1.67 | 6.73 ± 1.69 | 6.50 ± 1.67 | 0.001* |
| PLT, 109/L | 204.58 ± 55.82 | 208.39 ± 57.22 | 204.13 ± 55.64 | 0.058 |
Notes: Data are shown as means ± standard deviation, median (interquartile range), or numbers (percentages)
ECG Electrocardiogram, BMI Body mass index, FBG Fasting plasma glucose, TC Total cholesterol, TG Total triglyceride, Alb Albumin, Glo Globulin, UA Uric acid, SCr Serum creatinine, SU Serum urea, Hb Hemoglobin, RBC Red blood count, WBC White blood count, PLT Platelet count
* = statistically significant